Trump and RFK Jr. Take Aim at SSRIs: Understanding the Medications and Their Impact
2025-02-18
USA TODAY
Following Robert F. Kennedy Jr.'s confirmation as health secretary, President Donald Trump ordered an assessment of the potential threats posed to children by Selective Serotonin Reuptake Inhibitors (SSRIs). These medications, commonly used to treat depression and anxiety disorders, have sparked controversy and debate. As the administration reviews their effects, it's essential to understand how SSRIs work and their potential risks and benefits, including their role in mental health treatment and the importance of informed prescribing practices, particularly for children and adolescents, to ensure safe and effective use of antidepressants.